Skip to Main Content

The sole influenza vaccine made in cell culture in the United States may have worked about 20 percent better this flu season than the standard vaccines made in eggs, Food and Drug Administration Commissioner Scott Gottlieb said Thursday.

Gottlieb revealed that figure in a hearing of the congressional subcommittee on oversight and investigations, called to explore this year’s severe flu season and why flu vaccines did not appear to protect especially well.

advertisement

Gottlieb has said for several weeks that the FDA had data that suggested the cell-culture vaccine performed somewhat better, but this was the first time he publicly quantified the scale of the benefit.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$20

for 3 months, then $399/year

$20 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

To submit a correction request, please visit our Contact Us page.